These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1359697)

  • 41. Human SAA1-derived amyloid deposition in cell culture: a consistent model utilizing human peripheral blood mononuclear cells and serum-free medium.
    Ishii W; Liepnieks JJ; Yamada T; Benson MD; Kluve-Beckerman B
    Amyloid; 2013 Jun; 20(2):61-71. PubMed ID: 23461622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloidosis and the serum amyloid A protein response to muramyl dipeptide analogs and different mycobacterial species.
    McAdam KP; Foss NT; Garcia C; DeLellis R; Chedid L; Rees RJ; Wolff SM
    Infect Immun; 1983 Mar; 39(3):1147-54. PubMed ID: 6601620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis.
    Shtrasburg S; Pras M; Brezniak N; Dolitzki M; Livneh A
    J Lab Clin Med; 1999 Aug; 134(2):168-72. PubMed ID: 10444031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Animal models for reactive amyloidosis.
    Gruys E; Snel FW
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis.
    Kluve-Beckerman B; Hardwick J; Du L; Benson MD; Monia BP; Watt A; Crooke RM; Mullick A
    Amyloid; 2011 Sep; 18(3):136-46. PubMed ID: 21830877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid.
    Kluve-Beckerman B; Manaloor JJ; Liepnieks JJ
    Arthritis Rheum; 2002 Jul; 46(7):1905-13. PubMed ID: 12124875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1.
    Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Biochim Biophys Acta; 1995 Jan; 1270(1):81-6. PubMed ID: 7827140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor.
    Varga J; Flinn MS; Shirahama T; Rodgers OG; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):177-85. PubMed ID: 2874651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heme-oxygenase-1 response, a marker of oxidative stress, in a mouse model of AA amyloidosis.
    Kamalvand G; Pinard G; Ali-Khan Z
    Amyloid; 2003 Sep; 10(3):151-9. PubMed ID: 14640029
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
    de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
    Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
    Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
    Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species.
    Cui D; Kawano H; Takahashi M; Hoshii Y; Setoguchi M; Gondo T; Ishihara T
    Pathol Int; 2002 Jan; 52(1):40-5. PubMed ID: 11940205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Murine tissue macrophages synthesize and secrete amyloid proteins different to amyloid A (AA).
    Ramadori G; Rieder H; Sipe J; Shirahama T; Meyer zum Büschenfelde KH
    Eur J Clin Invest; 1989 Jun; 19(3):316-22. PubMed ID: 2478371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secondary, AA, Amyloidosis.
    Papa R; Lachmann HJ
    Rheum Dis Clin North Am; 2018 Nov; 44(4):585-603. PubMed ID: 30274625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.
    Muhammad N; Murakami T; Inoshima Y; Ishiguro N
    Clin Exp Immunol; 2015 Jul; 181(1):133-41. PubMed ID: 25736960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.
    Bansal A; Schmidt M; Rennegarbe M; Haupt C; Liberta F; Stecher S; Puscalau-Girtu I; Biedermann A; Fändrich M
    Nat Commun; 2021 Feb; 12(1):1013. PubMed ID: 33579941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolism of amyloid proteins.
    Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
    Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo.
    Husebekk A; Skogen B; Husby G; Marhaug G
    Scand J Immunol; 1985 Mar; 21(3):283-7. PubMed ID: 3922050
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.